George W. Lloyd - 17 Dec 2025 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Reporting relationship: EVP, Investments & CLO
Issuer ticker: RPRX
Reported as of: 17 Dec 2025
Net transaction value: -$4,240,333
SEC form: 4
Accepted by SEC: 19 Dec 2025, 17:24:49 UTC
Prior SEC filing: 05 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd

Key filing fact

George W. Lloyd filed Form 4 for Royalty Pharma plc (RPRX) on 19 Dec 2025.

Key facts

This page summarizes George W. Lloyd's Form 4 filing for Royalty Pharma plc (RPRX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 19 Dec 2025, 17:24.

Change

Previous filing in this sequence was filed on 05 Dec 2025.
Current net transaction value: -$4,240,333.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001814899 Primary reporting owner

Lloyd George W.

Relationship: EVP, Investments & CLO
Address: C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
Signature date: 19 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPRX transaction

Class A Ordinary Shares

Sale

Transaction value: $3,060,280
Shares: -79,346
Change %: -72%
Price: $38.57
Shares after: 30,654
Date: 17 Dec 2025
Ownership: By GWL 2014 G, LLC
Footnotes: F1, F2

RPRX transaction

Class A Ordinary Shares

Sale

Transaction value: $1,180,053
Shares: -30,654
Change %: -100%
Price: $38.50
Shares after: 0
Date: 18 Dec 2025
Ownership: By GWL 2014 G, LLC
Footnotes: F1, F3

RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 495,860
Date: 17 Dec 2025
Ownership: By GWL 2013 NG, LLC

RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 273,960
Date: 17 Dec 2025
Ownership: By IRA

RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,084
Date: 17 Dec 2025
Ownership: By GWL 2023 G HoldCo LLC

RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,011
Date: 17 Dec 2025
Ownership: By Spouse

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $38.87 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $38.67 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC remarks

In addition to the Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 7,527,320 Class A Ordinary Shares and Class E Ordinary Shares of Royalty Pharma Holdings Ltd ("RPH") exchangeable into 1,944,471 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions.